about
SNPs associated with cerebrospinal fluid phospho-tau levels influence rate of decline in Alzheimer's diseaseMeta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's diseaseIncreased expression of BIN1 mediates Alzheimer genetic risk by modulating tau pathologyStrong evidence that KIAA0319 on chromosome 6p is a susceptibility gene for developmental dyslexia.Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's diseaseSequence variation in the CHAT locus shows no association with late-onset Alzheimer's diseaseNo support for association between dyslexia susceptibility 1 candidate 1 and developmental dyslexiaGenetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer's diseaseGenome-wide association study of Alzheimer's disease with psychotic symptomsGWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease.Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's diseaseGene-wide analysis detects two new susceptibility genes for Alzheimer's disease.Deep sequencing of the Nicastrin gene in pooled DNA, the identification of genetic variants that affect risk of Alzheimer's disease.Suggestive synergy between genetic variants in TF and HFE as risk factors for Alzheimer's disease.The role of variation at AβPP, PSEN1, PSEN2, and MAPT in late onset Alzheimer's disease.Characterization of a family with rare deletions in CNTNAP5 and DOCK4 suggests novel risk loci for autism and dyslexia.Genome-wide analysis of genetic loci associated with Alzheimer disease.Follow-up of loci from the International Genomics of Alzheimer's Disease Project identifies TRIP4 as a novel susceptibility geneCharacterisation and validation of insertions and deletions in 173 patient exomesInteraction between the ADAM12 and SH3MD1 genes may confer susceptibility to late-onset Alzheimer's disease.Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease.Association analysis of 528 intra-genic SNPs in a region of chromosome 10 linked to late onset Alzheimer's disease.Meta-analysis of the association between variants in SORL1 and Alzheimer disease.Genome-wide association interaction analysis for Alzheimer's disease.No consistent evidence for association between mtDNA variants and Alzheimer disease.Genetic overlap between Alzheimer's disease and Parkinson's disease at the MAPT locusA novel Alzheimer disease locus located near the gene encoding tau protein.A genome-wide study shows a limited contribution of rare copy number variants to Alzheimer's disease risk.Estimation and partitioning of polygenic variation captured by common SNPs for Alzheimer's disease, multiple sclerosis and endometriosis.The Genetic Modifiers of Motor OnsetAge (GeM MOA) Website: Genome-wide Association Analysis for Genetic Modifiers of Huntington's Disease.Genome-wide haplotype association study identifies the FRMD4A gene as a risk locus for Alzheimer's diseaseShared genetic contribution to Ischaemic Stroke and Alzheimer's Disease.Common polygenic variation enhances risk prediction for Alzheimer's disease.Evidence that PICALM affects age at onset of Alzheimer's dementia in Down syndrome.Missense variant in TREML2 protects against Alzheimer's disease.Polymorphisms in BACE2 may affect the age of onset Alzheimer's dementia in Down syndrome.Genetic evidence for the involvement of lipid metabolism in Alzheimer's disease.Alzheimer's disease genetics: current knowledge and future challenges.From molecule to clinic and community for neurodegeneration: research to bridge translational gaps.Haplotype-based stratification of Huntington's disease.
P50
Q21144971-88406F6A-E59B-4E2A-BF15-068A3BFE0F8DQ22251067-B1A1746E-0492-4B0B-947B-A247497DA66DQ24316259-C5676204-8AB7-4BD9-A840-4B8C0816F33BQ24531462-89A560F6-6C41-479D-AAD2-53BA9C64DC40Q24612662-6F351A63-E96D-4513-BAC6-125E3CCA3691Q28205647-D1955537-FF2E-4190-9B1D-49E7E45530C9Q28287371-F903F9DC-531A-44A2-B853-8D641E9CC913Q28748461-17C21831-EEBA-46EE-BE5A-1AC5A27F0194Q29417042-8397D269-1C65-4391-A56A-90BA429A229EQ29417137-FCC3DE60-2FEE-4781-B788-5D780118765AQ29614879-DA0236F5-1EE4-4A7A-8B89-4C2727A89303Q33747916-672D6B22-1250-4871-8B49-7BB3BC66C32DQ33833796-90139855-B479-4727-8F21-25BEF9B8EB26Q33879307-3A4C0CE6-D124-4853-95DB-B0E6256CB1EDQ33986970-3FA49B04-A7B5-43F6-879A-195C5EFAAF57Q34134692-C9679E54-7B2E-4C77-9194-75A2BEAEEE28Q34339530-F1EFE8BD-D1E4-4A48-9A03-AA0A8C364024Q34402261-6BE1C0D4-E319-4DF9-9E86-2C7D292830B2Q34516375-78E62E46-B766-421E-9B24-9CD8149C1B3EQ34620094-5314052E-9FAF-4EDF-9B91-13A042953BE2Q34682478-CF9A11B3-8E96-4D3A-BBA5-CD9D5E864D59Q34731149-439CA8A7-95B1-437E-89BA-61AF30101A7FQ34913294-838362E3-B393-49EB-B320-99C93E9C4775Q35207630-CA8B20F6-2AD6-450D-92B8-827A776E4726Q35865691-281953F1-A2CC-4057-B95A-33B3CACC5581Q35963497-A74A0B71-0A58-4EB6-93BC-A4798FDAB978Q36070145-5C1C64E4-32C8-493E-B03E-ABC36F084955Q36559977-14118C9B-DCA6-4E23-8A49-1C9E9D3FD548Q36560009-97466D18-BCD0-443B-BC62-AB1B578D8346Q36579812-40B5EB0C-C23E-4369-A0C1-CB46BC27EE57Q36712361-FD5BAEA0-C3F6-4C2B-96EB-502603814925Q36895476-7EF39A60-6504-43D4-B5DA-64ED0CF37B3DQ37220545-195FF7F0-31D9-40A6-9F16-28BF84601880Q37503442-07010DA6-E016-4A8F-9E99-69DF82578399Q37653009-437FA5CC-CB89-4087-9B0F-1B16B5B6733AQ37671444-E0D75A14-A8DF-44D3-B0D8-C3226D12630AQ37737398-012850CE-E7DA-425C-9BB1-343860FC1FE3Q37801363-77FCE20C-D891-4B73-9474-F6256F1386BCQ38014593-1A75258F-FEC5-434F-B974-1B975107C52CQ38612630-92B84FD4-84B1-4C1F-9BEA-863261DBDB49
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Denise Harold
@ast
Denise Harold
@en
Denise Harold
@es
Denise Harold
@nl
Denise Harold
@sl
type
label
Denise Harold
@ast
Denise Harold
@en
Denise Harold
@es
Denise Harold
@nl
Denise Harold
@sl
altLabel
D Harold
@en
prefLabel
Denise Harold
@ast
Denise Harold
@en
Denise Harold
@es
Denise Harold
@nl
Denise Harold
@sl
P106
P1153
57201305725
6603459418
P21
P31
P496
0000-0001-5195-0143
P569
2000-01-01T00:00:00Z